Spruce Biosciences, Inc.

US$46.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SPRBHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (44.67%)
Div yield —
ROE (105.98%)
Biotechnology
Beta (5Y) 3.54
PE TTM —
TSR TTM (57.72%)
Mkt cap US$133.8M
ROIC (46.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$46
(1.15%)
34.11%
Hold 9|3|5|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.01
0.98
0.96
1.02
23.84%
18.51%
4.61%
2.72%
Revenue$M
10.13
10.33
10.08
10.13
2.85%
5.94%
6.09%
2.84%
Peers (US$133.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.439
0.012
0.017
EBIT/Intx
1.076
1.798
1.475
Own earn%
12.76
30.41
32.16
Sh yield%
12.78
38.58
38.10
Owners
Insiders/Inst%
5.68
52.05
Short interest%
1.03
SBC / revenue%
3.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
9